NCT04352621: Study to Assess the Effects of Intranasal Ketamine Along With rTMS for Patients With Treatment-resistant Major Depressive Disorder (TRD)
- State
- State not given
- Phase
- Phase 4
- People
- 20 planned
- Started
- 1 May 2020
- Primary completion
- 1 May 2022
- Arms
- Ketamine plus rTMS
- Results
- None posted
- 20 Apr 2020: Trial registered